Lucid Diagnostics (LUCD) Income from Continuing Operations (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Income from Continuing Operations came in at 13909000.0 in Q1 2026, up 48.31% YoY from 9378389.05 in Q1 2025, and up 14.49% on a QoQ basis from 16266000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Income from Continuing Operations data on file, last reported at 13909000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 48.31% year-over-year to 13909000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 45011000.0 (up 27.2% YoY) and the FY2025 annual result came in at 58010000.0, down 27.41% from the prior year.
- Income from Continuing Operations climbed to 13909000.0 in Q1 2026, from 16266000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 4439000.0 in Q2 2025 to a low of 26908000.0 in Q1 2025.
- A 5-year average of 13310882.35 and a median of 12371000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 235.89% — and 2025, when it jumped 59.66%.
- Tracing LUCD's Income from Continuing Operations over 5 years: stood at 14928000.0 in 2022, then rose by 27.45% to 10830000.0 in 2023, then decreased by 6.57% to 11541000.0 in 2024, then plunged by 40.94% to 16266000.0 in 2025, then rose by 14.49% to 13909000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 13909000.0 (Q1 2026), 16266000.0 (Q4 2025), and 10397000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Lucid Diagnostics | 176.26 Mn | 142.85 Mn | 55,000.00 | -11.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.69 Mn |
| Mar 31, 2026 | -13.91 Mn |
| Dec 31, 2025 | -16.27 Mn |
| Sep 30, 2025 | -10.40 Mn |
| Jun 30, 2025 | -4.44 Mn |
| Mar 31, 2025 | -26.91 Mn |
| Dec 31, 2024 | -11.54 Mn |
| Sep 30, 2024 | -12.37 Mn |
| Jun 30, 2024 | -11.01 Mn |
| Mar 31, 2024 | -10.61 Mn |
| Dec 31, 2023 | -10.83 Mn |
| Sep 30, 2023 | -14.21 Mn |
| Jun 30, 2023 | -11.38 Mn |
| Mar 31, 2023 | -16.25 Mn |
| Dec 31, 2022 | -14.93 Mn |
| Sep 30, 2022 | -14.35 Mn |
| Jun 30, 2022 | -14.62 Mn |
| Mar 31, 2022 | -12.27 Mn |
| Dec 31, 2021 | -11.31 Mn |
| Sep 30, 2021 | -6.96 Mn |